Message Image

Skip main navigation (Press Enter).

Approval of an intravenous secukinumab regimen not tested in clinical trial – FDA and Novartis persp

MIDD Series: Approval of an intravenous secukinumab regimen not tested in clinical trial – FDA and Novartis perspectives on this Model Informed Drug Development application

Event Image

When: Mar 19, 2025 from 12:00 to 13:00 (ET)

Register Now

Download to Your Calendar

Location

Online Instructions:

Url: http://learn.isop.org/
Login: Login to the ISoP Learning Center

Other Upcoming Webinars and Events

ICoP India

Feb 1 - 2, (IST)
From Basics to Best Practices: Understanding machine learning model predictions in drug development

Feb 18, 12:00 - 13:00 (ET)
From concept to harmonized framework: An Overview of the Draft ICH M15 Guideline on Model-Informed D

Feb 25, 09:00 - 11:00 (ET)
Approval of an intravenous secukinumab regimen not tested in clinical trial – FDA and Novartis persp

Mar 19, 12:00 - 13:00 (ET)
Semi-mechanistic PK/PD modeling and simulation of sequential siRNA and bepirovirsen treatment to inf

Apr 16, 12:00 - 13:00 (ET)
PAGE

Jun 3 - 6, (EET)
ACoP 2025

Oct 18 - 21, (MT)

Powered by Higher Logic